InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: ahab333 post# 42689

Thursday, 01/04/2018 8:55:00 PM

Thursday, January 04, 2018 8:55:00 PM

Post# of 48316
I think it took the hiring of the new CEO, Dan O'Connor to get this ship pointed in the right direction. He said it himself that the recently presented data was the only reason he joined Oncosec, so I believe that he truly believes he can make a successful pipeline happen here. 2 IST trials with anti-pd1 (no cost to Oncosec and obviously drug provided by Merck), TNBC trial (might be with Opdivo drug supply from Bristol Myers...according to an unconfirmed twitter message).....we will see. Also PIIM trial and probably collaborations and partnerships on the horizon. SITC data in November definitely shook things up a bit. 2018 is gonna be great for Oncosec.....and it has been a long time coming. Glad I am still a shareholder too. Good Luck Ahab!